SHI Jinhai 史晋海

Jinhai Shi,PhD

  • Chief Medical Executives, Bing BioTech Limited
  • Co-founder & General Secretary, China Protein Drug Quality Alliance
  • Adjunctive Professors, Peking University & Tianjin University

Dr. Shi worked for Amgen for more than a decade, with a variety of positions in drug development. His over 20-years’experience of clinical practices, drug development, multiple global project management in clinical study, health economics and drug safety made him as Product Team Leader for many products developed in Amgen. Since 2011, he has been Vice President of Tianjin International Joint Academy of Biomedicine in charge of innovative drug R&D, and actively participates in many China bio-industry policy studies. He is a co-founder and General Secretary of China Protein Drug Quality Alliance, adjunctive professors of Peking University & Tianjin University.